Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the anti-psoriatic effect of LP0113 aerosol spray compared to Daivobet® gel, LEO 90100 aerosol foam, betamethasone dipropionate in the aerosol spray vehicle, calcipotriol in the aerosol spray vehicle and aerosol spray vehicle.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02416258
Study type Interventional
Source LEO Pharma
Contact
Status Completed
Phase Phase 2
Start date April 2015
Completion date June 2015

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04971200 - Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo Early Phase 1
Active, not recruiting NCT05525741 - Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients N/A
Completed NCT02379793 - Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects Phase 1
Completed NCT01093911 - Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) Phase 1
Completed NCT00147511 - Time To Efficacy and Onset Of Action Of Linezolid Phase 4
Completed NCT02355639 - A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin Phase 1
Completed NCT01764594 - Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus Phase 1
Active, not recruiting NCT05185258 - Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study Phase 4
Completed NCT02985437 - Safety and Tolerability of Topically Applied Bovine Lung Surfactant on Intact Skin Phase 1
Not yet recruiting NCT06427889 - Treatment Effects of Two Pharmaceutical Skin Care Creams for Xerotic Feet Among Persons With Diabetes Phase 4
Completed NCT02518048 - A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris Phase 2
Withdrawn NCT03196115 - Biomarker for Hyaline Fibromatosis Syndrome (BioHFS)